Antiatherosclerotic effects of calcium channel blockers

This publication has 74 references indexed in Scilit:

• Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?
  International Journal of Cardiology, 1997
• Endothelial Function
  Drugs, 1997
• A new generation of calcium antagonists and their role in atherosclerosis
  The American Journal of Cardiology, 1990
• Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)
  Cardiovascular Drugs and Therapy, 1990
• Antiatherogenic effects of calcium-channel blockers: Possible mechanisms of action
  Cardiovascular Drugs and Therapy, 1990
• Effects of calcium antagonists on lipids and atherosclerosis
  The American Journal of Cardiology, 1989
• Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary arterial narrowings in angina pectoris
  The American Journal of Cardiology, 1989
• The role of calcium in the pathogenesis of experimental arteriosclerosis
  Trends in Pharmacological Sciences, 1987
• Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
• Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit
  The American Journal of Cardiology, 1984